RLFTF
RELIEF THERAPEUTICS HLDG AG

Relief is a Swiss, commercial-stage, biopharmaceutical company focused on identification, development and commercialization of novel, patent-protected products intended for the treatment of rare and ultra-rare diseases including dermatologic disorders, metabolic disorders, and pulmonary diseases. The parent company of the group, RELIEF THERAPEUTICS Holding SA, is listed on the SIX Swiss Exchange under the symbol RLF and quoted in the U.S. on OTCQB under the symbols RLFTF and RLFTY.